New technology will be in place from January 31 to monitor advertisements on social media relating to the promotion of prescription-only medicines (POMs) such as botulinum toxin.
The Committees of Advertising Practice (CAP) has issued an Enforcement Notice following recent reports of education providers not adhering to its advertising rules for promoting training for injectable procedures.
The Aesthetic Complications Expert (ACE) Group World has released new guidance on dermal filler delayed onset reactions following COVID-19 infection and vaccination.
Consultant plastic and reconstructive surgeon Mr Dalvi Humzah has launched a new ultrasound development course.
The UK Government has announced its intention to introduce a new system of licensing in England for cosmetic procedures which will be tabled today.
New research has revealed that one in six people suffer complications after having botulinum toxin injections.
Adverse events from the use of dermal fillers are being reported at three per 1,000 treatments, according to data collected from members of the British College of Aesthetic Medicine (BCAM).
The UK distributor of IBSA Derma’s products, HA-Derma, is hosting a free webinar on May 17 regarding complications arising with hyaluronic acid (HA) injectable treatments.
The Committee of Advertising Practice (CAP) has introduced a new restriction that prohibits cosmetic interventions advertising being directed at under-18s.
A statement by the Association for Cosmetic Practitioners Britain (ACPB) has been released today in response to the recent Joint Council for Cosmetic Practitioners' (JCCP) announcement to only allow healthcare professionals onto Part 1 of the JCCP Practitioner Register.